In the present study, we highlighted that miR-212-3p inhibited SP1 and BACE1 to block the activation of the NLRP3/Caspase-1 signaling pathway, thus attenuating neuroinflammation in AD rats (Figure 7). This evidence concerns the gene SP1 and Alzheimer disease.